A high-performance liquid chromatography-mass spectrometry assay for quantitation of the tyrosine kinase inhibitor nilotinib in human plasma and serum
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-07-01
著者
-
Parise Robert
Molecular Therapeutics/drug Discovery Program University
-
Egorin Merrill
Molecular Therapeutics/drug Discovery Program University
-
Beumer Jan
Molecular Therapeutics/drug Discovery Program University
-
Parise Robert
Molecular Therapeutics/drug Discovery Program University Of Pittsburgh Cancer Institute
-
Egorin Merrill
Molecular Therapeutics/drug Discovery Program University Of Pittsburgh Cancer Institute
-
Beumer Jan
Department Of Pharmaceutical Sciences University Of Pittsburgh School Of Pharmacy
-
Parise Robert
Department Of Pharmaceutical Sciences University Of Pittsburgh School Of Pharmacy
-
Zhou Wei
Novartis Institutes For Biomedical Research Translational Sciences Dmpk-dmba
-
CHRISTNER Susan
Molecular Therapeutics/Drug Discovery Program, University of Pittsburgh Cancer Institute
-
SHAH Dhvani
Molecular Therapeutics/Drug Discovery Program, University of Pittsburgh Cancer Institute
-
Shah Dhvani
Molecular Therapeutics/drug Discovery Program University Of Pittsburgh Cancer Institute
-
Christner Susan
Molecular Therapeutics/drug Discovery Program University Of Pittsburgh Cancer Institute
関連論文
- Liquid chromatography-electrospray tandem mass spectrometric assay suitable for quantitation of halofuginone in plasma
- Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma
- Quantitative determination of zebularine (NSC 309132), a DNA methyltransferase inhibitor, and three metabolites in murine plasma by high-performance liquid chromatography coupled with on-line radioactivity detection
- Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma
- A liquid chromatography-electrospray ionization tandem mass spectrometric assay for quantitation of the histone deacetylase inhibitor, vorinostat (suberoylanilide hydroxamicacid, SAHA), and its metabolites in human serum
- Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma
- A high-performance liquid chromatography-mass spectrometry assay for quantitation of the tyrosine kinase inhibitor nilotinib in human plasma and serum
- Liquid chromatography-mass spectrometric assay for the quantitation in human plasma of ABT-888, an orally available, small molecule inhibitor of poly(ADP-ribose) polymerase